Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Kathryn Guarini

At a glance: Kathryn Guarini is Director at Regeneron Pharmaceuticals (REGN). Their latest SEC Form 4, filed Nov 3, 2026, reported a sale of $360K. On file: 0 purchase lines ($0) and 3 sale lines ($1.0M).

Disclosed holdings: about $562K of REGN stock: 603 shares reported on their latest Form 4 (filed Nov 3, 2026), valued at the Nov 19, 2026 close of $932.53. This counts only REGN shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

Director at Regeneron Pharmaceuticals, Inc. (REGN)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.0M

Kathryn Guarini's InsiderPrint

3 trades from SEC Form 4 filings, 2026 to 2026, drawn as one fingerprint.

InsiderPrint of Kathryn Guarini: 3 trades, 2026 to 20262026: 0 buys, 3 sales

Reading this print: Almost only sells, trading about 3 times a year, typically $340K a trade; most sales are on a pre-planned 10b5-1 schedule.

  • Bump outward: a purchase (0)
  • Dent inward: a sale (3)
  • One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.

Insiders with a similar print

  1. Pedro R. BuhigasChief Information Officer · KGS · 100% match
  2. Christopher L. SchremserCTO · WAY · 100% match
  3. Christopher T. HandmanGeneral Counsel · ROKU · 100% match
  4. Wendell WierengaDirector · CYTK · 100% match
  5. Michael John ShortPresident · CHRW · 100% match

Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.

Reported trades

Filed Stock Type Shares Price Value Since
Nov 3SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 400603 held (−40%) $900.00 $360K +3.6%
Sep 3SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 400603 held (−40%) $850.00 $340K +9.7%
Aug 12SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 400603 held (−40%) $800.00 $320K +16.6%
  • Sell

    Director Kathryn Guarini sold $360K of REGN at $900.00 — cuts the stake by 40%; pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Kathryn Guarini sold $340K of REGN at $850.00 — cuts the stake by 40%; pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Kathryn Guarini sold $320K of REGN at $800.00 — cuts the stake by 40%; pre-scheduled 10b5-1 plan sale.

Follow Kathryn Guarini

Get one email when Kathryn Guarini files a new purchase or sale. Free.

At most one email a day about Kathryn Guarini, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.